Patents by Inventor Bernard R. Brodeur

Bernard R. Brodeur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STREPTOCOCCUS PYOGENES POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20090186820
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.
    Type: Application
    Filed: January 12, 2009
    Publication date: July 23, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Patrick Rheault
  • MORAXELLA (BRANHAMELLA) CATARRHALIS ANTIGENS
    Publication number: 20090074807
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamella) catarrhalis which may be useful for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: July 15, 2008
    Publication date: March 19, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Josee Hamel, Bernard R. Brodeur, Stephane Rioux, Julie Couture
  • GROUP B STREPTOCOCCUS ANTIGENS AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20090042794
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: June 9, 2008
    Publication date: February 12, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Martine Boyer
  • polypeptides and corresponding DNA fragments
    Patent number: 7482012
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: January 27, 2009
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Patrick Rheault
  • BVH-A2 AND BVH-A3 ANTIGENS OF GROUP B STREPTOCOCCUS
    Publication number: 20080227706
    Abstract: Group B Streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Application
    Filed: January 22, 2008
    Publication date: September 18, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josee Hamel, Bernard R. Brodeur
  • () antigens
    Patent number: 7410645
    Abstract: The present invention relates to polypeptides of Moraxella(Branhamella) catarrhalis which may be useful for prophylaxis, diagnosis and/or therapy purposes.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: August 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture
  • Polypeptides of ()
    Patent number: 7410648
    Abstract: The present invention relates to polypeptides, more particularly polypeptides of Moraxella (Branhamella) catarrhalis which may be used to prevent, diagnose and/or treat Moraxella (Branhamella) catarrhalis infection.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: August 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture
  • Group B antigens and corresponding DNA fragments
    Patent number: 7393536
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: July 1, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stéphane Rioux, Bernard R. Brodeur, Josée Hamel, Martine Boyer
  • PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
    Publication number: 20080124337
    Abstract: The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to Proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoeae strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 29, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Bernard R. Brodeur, Denis Martin, Josee Hamel, Clement Rioux
  • PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
    Publication number: 20080124353
    Abstract: The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to Proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoeae strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 29, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Bernard R. Brodeur, Denis Martin, Josee Hamel, Clement Rioux
  • PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
    Publication number: 20080124351
    Abstract: The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to Proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoeae strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 29, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Bernard R. Brodeur, Denis Martin, Josee Hamel, Clement Rioux
  • BVH-A2 and BVH-A3 antigens of group B
    Patent number: 7335368
    Abstract: Group B streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: February 26, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josée Hamel, Bernard R Brodeur
  • () polypeptides and corresponding DNA fragments
    Patent number: 7329500
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamela) catarrhalis which may be used for prophy-laxis, diagnostic and/or therapy purposes.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: February 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture
  • Proteinase K resistant surface protein of neisseria meningitidis
    Patent number: 7273611
    Abstract: The identification of a highly conserved, immunologically accessible antigen on the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoaea strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: September 25, 2007
    Assignee: ID Biomedical Corporation
    Inventors: Bernard R. Brodeur, Denis Martin, Josee Hamel, Clement Rioux
  • antigens
    Patent number: 7262024
    Abstract: The present invention relates to polypeptides of Streptococcus pneumoniae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: August 28, 2007
    Assignee: ID Biomedical Corporation
    Inventors: Josée Hamel, Nathalie Charland, Bernard R. Brodeur, Denis Martin, Normand Blais, Catherine Ouellet, Steve Labbe
  • antigens
    Patent number: 7128918
    Abstract: Streptococcus proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: October 31, 2006
    Assignee: ID Biomedical Corporation
    Inventors: Josee Hamel, Bernard R. Brodeur, Isabelle Pineau, Denis Martin, Clement Rioux, Nathalie Charland
  • Moraxella(branhamella) catarrhalis antigens
    Publication number: 20040236087
    Abstract: The present invention relates to polypeptides of Moraxella(Branhamella) calarrhalis which may be useful for prophylaxis, diagnosis and/or therapy purposes.
    Type: Application
    Filed: June 2, 2004
    Publication date: November 25, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard R. Brodeur, Stephane Rioux, Julie Couture
  • Haemophilus influenzae antigens and corresponding dna fragments
    Publication number: 20040171802
    Abstract: The present invention relates to polypeptides of Haemophilus influenzae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: April 2, 2003
    Publication date: September 2, 2004
    Inventors: Josee Hamel, France Couture, Bernard R. Brodeur, Denis Martin, Catherine Quellet, Mireille Tremblay, Annie Charbonneau, Catherine Vayssier
  • Antigens of group b streptococcus and corresponding dna fragments
    Publication number: 20040171113
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: April 19, 2004
    Publication date: September 2, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard R Brodeur, Stephane Rioux, Martine Boyer
  • Streptococcus antigens
    Publication number: 20030232976
    Abstract: The present invention relates to polypeptides of Streptococcus pneumoniae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: December 20, 2002
    Publication date: December 18, 2003
    Inventors: Josee Hamel, Nathalie Charland, Bernard R. Brodeur, Denis Martin, Normand Blais, Catherine Ouellet, Steve Labbe